FOSB and acute myeloid leukemia: In these common signatures, several have been proved to be associated with better outcome in AML, such as FOSB, miR-335, miR-181 family members etc. These results further illustrated the possibility of combining let-7a-2–3p and miR-188–5p as prognostic biomarkers for CN-AML patients.